ARTICLE | Clinical News
Levobupivacaine data
January 22, 1996 8:00 AM UTC
Chiroscience announced results from the first of two Phase III U.K. trials. In 97 patients undergoing lower limb surgery, the product displayed the same anesthetic properties as racemic bupivacaine.
A previous study showed that levobupivacaine had one-third of the cardiotoxicity of racemic bupivacaine, the company said. ...